Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 7/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3644918 | 0.84 | MAPT (0.51) | ACACBSMN1; SMN2LMNATDP1ADRB2 | |
| SCHEMBL12377127 | 0.84 | POLB (0.64) | ACACBSMN1; SMN2LMNATDP1ADRB2 | |
| SCHEMBL28281696 | 0.83 | MAPK1 (0.59) | SMN1; SMN2TDP1KDM4ECYP1A2TSHR | |
| SCHEMBL25376920 | 0.83 | GPR88 (0.46) | — | |
| SCHEMBL6201961 | 0.83 | LMNA (0.65) | ACACBSMN1; SMN2LMNATDP1ADRB2 | |
| SCHEMBL13762874 | 0.81 | MAPT (0.53) | ACACBSMN1; SMN2LMNATDP1ADRB2 | |
| SCHEMBL4751700 | 0.81 | ALDH1A1 (0.54) | ACACBSMN1; SMN2LMNATDP1ADRB2 | |
| SCHEMBL20794553 | 0.81 | LMNA (0.49) | ACACBSMN1; SMN2LMNATDP1ADRB2 | |
| SCHEMBL10921397 | 0.81 | FAAH (0.47) | NR1H4MAPTMEN1KMT2AFAAH | |
| SCHEMBL2528806 | 0.80 | ALDH1A1 (0.54) | SMN1; SMN2LMNATDP1KDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635568-A2 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | ACADIA Pharmaceuticals Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-3672954-B1 | COMPOUNDS, SALTS THEREOF AND THEIR USE FOR THE TREATMENT OF DISEASES | ACADIA PHARM INC (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20250197385-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | ACADIA PHARM INC (US) | 2025-06-19 | — | — | US | disclosed |
| US-12139477-B2 | Compounds, salts thereof and methods for treatment of diseases | ACADIA PHARMACEUTICALS INC. (US) | 2024-11-12 | — | — | US | disclosed |
| CN-117466803-A | Compounds, salts thereof and methods for treating diseases | 阿卡蒂亚药品公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-111132976-B | Compounds, salts thereof and methods for treating diseases | 阿卡蒂亚药品公司 | 2023-08-22 | — | — | CN | disclosed |
| US-20220298151-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | ACADIA PHARMACEUTICALS INC. (US) | 2022-09-22 | — | — | US | disclosed |
| US-11440884-B2 | Compounds, salts thereof and methods for treatment of diseases | ACADIA PHARMACEUTICALS INC. (US) | 2022-09-13 | — | — | US | disclosed |
| US-11345693-B2 | Compounds, salts thereof and methods for treatment of diseases | ACADIA PHARMACEUTICALS INC. (US) | 2022-05-31 | — | — | US | disclosed |
| US-11345693-B2 | Compounds, salts thereof and methods for treatment of diseases | ACADIA PHARMACEUTICALS INC. (US) | 2022-05-31 | — | — | US | disclosed |
| US-4271186-A | Stilbene compounds and insecticidal/acaricidal compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1981-06-02 | — | — | US | disclosed |
| US-4266074-A | SUBSTITUTED PHENYL BUTENYL ACETATES | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1981-05-05 | — | — | US | disclosed |
| US-4261920-A | INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-14 | — | — | US | disclosed |
| US-4242357-A | INSECTICIDES, MITICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| US-4218469-A | Combating arthropods with 3-phenoxy-fluoro-benzyl carboxylic acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1980-08-19 | — | — | US | disclosed |
| US-4062968-A | MITICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-12-13 | — | — | US | disclosed |
| US-4058622-A | Substituted phenyl acetate, insecticidal composition and method of use | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-11-15 | — | — | US | disclosed |
| US-4039680-A | SULFUR CONTAINING HETEROCYCLES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-08-02 | — | — | US | disclosed |
| US-4031235-A | Insecticidal substituted acetate compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-21 | — | — | US | disclosed |
| US-3996244-A | Insecticidal esters of substituted furan methanol | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220298151-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | SLC10A1, CYP27A1, CYP11B2 | ACACB 417/4885SMN1; SMN2 451/4885LMNA 1628/4885 |
| US-12139477-B2 | Compounds, salts thereof and methods for treatment of diseases | SLC10A1, CYP27A1, CYP11B2 | ACACB 417/4885SMN1; SMN2 451/4885LMNA 1628/4885 |
| US-11345693-B2 | Compounds, salts thereof and methods for treatment of diseases | SLC10A1, CYP27A1, CYP11B2 | ACACB 417/4885SMN1; SMN2 451/4885LMNA 1628/4885 |
| US-11440884-B2 | Compounds, salts thereof and methods for treatment of diseases | SLC10A1, VHL, CYP11B2 | ACACB 759/4885SMN1; SMN2 369/4885LMNA 1469/4885 |
| US-20250197385-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | SLC10A1, CYP27A1, CYP11B2 | ACACB 417/4885SMN1; SMN2 451/4885LMNA 1628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.